4.6 Article

Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia

Journal

ATHEROSCLEROSIS
Volume 207, Issue 2, Pages 471-475

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2009.06.006

Keywords

Dyslipidemia; Atherosclerosis; Endothelium; Inflammation; Children

Ask authors/readers for more resources

Objectives: Prospective studies demonstrated an increased cardiovascular risk in subjects with high levels of either the endothelial-platelet activation marker P-selectin or high-sensitivity C-reactive protein (hs-CRP). Both children with heterozygous familial hypercholesterolemia (FH) and those with familial combined hyperlipidemia (FCHL) are prone to premature atherosclerosis. Our objective was to investigate in children with either FH or FCHL whether P-selectin and hs-CRP contribute to carotid intima-media thickness (IMT), along with increased plasma lipid levels. Methods: Carotid IMT, serum lipids and soluble P-selectin and hs-CRP levels were measured in 88 children (mean age 10.5 +/- 4.3 years) including 44 dyslipidemic children (25 with FH and 19 with FCHL) and 44 non-dyslipidemic controls. Results: Carotid IMT was significantly higher among dyslipidemic than in control children (0.46 +/- 0.06 mm vs 0.43 +/- 0.06 mm, p = 0.003) and serum P-selectin levels as well [129(50-254) ng/mL vs 50(24.5-130) ng/ mL, p < 0.001]. FH but not FCHL children had higher hs-CRP levels than controls [0.7(0.01-6.9) mg/L vs 0.3(0.1-1.2) mg/L, p = 0.006]. In the entire sample of dyslipidemic children, carotid IMT was positively associated with soluble P-selectin levels (rho = 0.30, p = 0.049), but not with hs-CRP. The association between P-selectin and carotid IMT was independent from confounders, including plasma lipid levels. Conclusion: Endothelial-platelet activation, more than low-grade systemic inflammation, correlates with premature atherosclerosis among children with familial dyslipidemia, this association being independent from plasma lipid levels. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study

Roberto Cangemi, Camilla Calvieri, Marco Falcone, Francesco Cipollone, Giancarlo Ceccarelli, Pasquale Pignatelli, Damiano D'Ardes, Matteo Pirro, Francesco Alessandri, Miriam Lichtner, Gabriella D'Ettorre, Alessandra Oliva, Raissa Aronica, Monica Rocco, Mario Venditti, Giulio Francesco Romiti, Giusy Tiseo, Gloria Taliani, Francesco Menichetti, Francesco Pugliese, Claudio Maria Mastroianni, Francesco Violi

Summary: Compared with CAP, COVID-19 is associated with a higher burden of thrombotic events, different types of thrombosis, and a higher risk of thrombosis-related in-hospital mortality.

THROMBOSIS AND HAEMOSTASIS (2022)

Article Peripheral Vascular Disease

Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention

Massimo Volpe, Giovanna Gallo, Maria Grazia Modena, Claudio Ferri, Giovambattista Desideri, Giuliano Tocci

Summary: This executive document reflects and updates the key points of a Consensus document on Cardiovascular Prevention. It analyzes and discusses the new recommendations introduced by international guidelines and highlights the importance of effective CV prevention strategies during the COVID-19 outbreak.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2022)

Review Medicine, General & Internal

The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis

Amir Vahedian-Azimi, Massimo R. Mannarino, Sajad Shojaie, Farshid Rahimibashar, Hadi Esmaeili Gouvarchin Galeh, Maciej Banach, Vanessa Bianconi, Matteo Pirro, Amirhossein Sahebkar

Summary: The meta-analysis showed that ongoing statin treatment can reduce the prevalence of influenza virus infection and improve survival rates associated with influenza.

ARCHIVES OF MEDICAL SCIENCE (2022)

Article Pathology

The detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-19

Vanessa Bianconi, Massimo R. Mannarino, Filippo Figorilli, Elena Cosentini, Giuseppe Batori, Ettore Marini, Maciej Banach, Amirhossein Sahebkar, Matteo Pirro

Summary: This study evaluated the impact of serum ferritin-to-iron ratio (FIR) on the prognosis of hospitalized patients with COVID-19. The findings showed that higher FIR values were associated with more severe symptoms and increased risk of ICU admission/in-hospital death.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2022)

Article Hematology

The ADA (Age-D-Dimer-Albumin) Score to Predict Thrombosis in SARS-CoV-2

Francesco Violi, Pasquale Pignatelli, Anna Rita Vestri, Alessandra Spagnoli, Francesco Cipollone, Giancarlo Ceccarelli, Alessandra Oliva, Maria Amitrano, Matteo Pirro, Gloria Taliani, Roberto Cangemi, Miriam Lichtner, Francesco Pugliese, Marco Falcone, Damiano D'Ardes, Mario Venditti, Claudio Maria Mastroianni, Lorenzo Loffredo

Summary: This study found that a new score (ADA score) combining age, D-dimer, and albumin can be used to predict the risk of thrombosis in patients with SARS-CoV-2. The ADA score can help identify high-risk patients.

THROMBOSIS AND HAEMOSTASIS (2022)

Review Geriatrics & Gerontology

Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

Peter E. Penson, Eric Bruckert, David Marais, Zeljko Reiner, Matteo Pirro, Amirhossein Sahebkar, Gani Bajraktari, Erkin Mirrakhimov, Manfredi Rizzo, Dimitri P. Mikhailidis, Alexandros Sachinidis, Dan Gaita, Gustavs Latkovskis, Mohsen Mazidi, Peter P. Toth, Daniel Pella, Fahad Alnouri, Arman Postadzhiyan, Hung- Yeh, G. B. John Mancini, Stephan von Haehling, Maciej Banach

Summary: Statin intolerance is a clinical syndrome that may lead to the discontinuation of therapy and an increased risk of adverse cardiovascular outcomes. Clear guidance is needed to manage perceived adverse effects and improve long-term compliance with lipid-lowering therapy. The International Lipid Expert Panel has proposed a patient-centered approach to address these issues.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Medicine, General & Internal

Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

Sebastiano Cicco, Marco D'Abbondanza, Marco Proietti, Vincenzo Zaccone, Chiara Pes, Federica Caradio, Massimo Mattioli, Salvatore Piano, Alberto Maria Marra, Alessandro Nobili, Pier Mannuccio Mannucci, Antonello Pietrangelo, Giorgio Sesti, Elena Buzzetti, Andrea Salzano, Antonio Cimellaro

Summary: This study investigated the determinants and outcomes of antihypertensive drug prescription in older hospitalized patients. The findings suggest that adherence to guideline-recommended antihypertensive treatment is associated with a lower risk of adverse clinical outcomes.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Medicine, General & Internal

Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients

Lorenzo Loffredo, Pasquale Pignatelli, Matteo Pirro, Giancarlo Ceccarelli, Alessandra Oliva, Enrico Maggio, Francesca Cancelli, Damiano D'Ardes, Maria Amitrano, Anna Maria Zicari, Bianca Laura Cinicola, Gloria Taliani, Roberto Cangemi, Miriam Lichtner, Marco Falcone, Federica Orlando, Francesco Pugliese, Mario Venditti, Claudio Maria Mastroianni, Francesco Violi

Summary: The P/F ratio is associated with thrombotic events in COVID-19 patients. A low P/F ratio is associated with thrombocytosis, which may lead to clot formation. This study suggests that the P/F ratio is closely related to thrombotic events in patients with COVID-19.

INTERNAL AND EMERGENCY MEDICINE (2023)

Article Medicine, Research & Experimental

Causal analysis of plasma IL-8 on carotid intima media thickness, a measure of subclinical atherosclerosis

Ilais Moreno Velasquez, Anders Malarstig, Damiano Baldassarre, Yan Borne, Ulf de Faire, Gunnar Engstrom, Per Eriksson, Philippe Giral, Steve E. Humphries, Sudhir Kurl, Karin Leander, Lars Lind, Anders Linden, Nicola Orsini, Matteo Pirro, Angela Silveira, Andries J. Smit, Elena Tremoli, Fabrizio Veglia, Rona J. Strawbridge, Bruna Gigante

Summary: The study found a causal relationship between plasma IL-8 and carotid intima-media thickness (c-IMT), a measure of sub-clinical atherosclerosis. The association was confirmed through quantile regression analysis in the multicenter European study IMPROVE, and genetic variants were identified to be associated with both IL-8 levels and c-IMT measures. Replication and meta-analysis further supported the effect of IL-8 on c-IMT.

CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2023)

Article Virology

The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19

Vanessa Bianconi, Massimo R. Mannarino, Elena Cosentini, Filippo Figorilli, Cecilia Colangelo, Giulia Cellini, Marco Braca, Rita Lombardini, Rita Paltriccia, Amirhossein Sahebkar, Matteo Pirro

Summary: This study found that preadmission statin therapy is associated with a reduced risk of intensive care unit admission or in-hospital death among patients with COVID-19 at high CV risk. Furthermore, statin therapy is associated with improved endothelial function. However, the interaction between endothelial function and statin therapy is not associated with in-hospital outcomes.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Pharmacology & Pharmacy

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach

Summary: Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition with a high prevalence in adults, children, and individuals with type 2 diabetes mellitus. It is a leading cause of liver-related morbidity and cardiovascular mortality. The use of nutraceuticals in managing NAFLD has been suggested, but there is currently insufficient evidence to support their routine use. Further rigorous trials are needed to evaluate their efficacy and safety.

PHARMACOLOGICAL RESEARCH (2023)

Review Chemistry, Medicinal

The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials

Sahar Dadkhah Tehrani, Mehrnaz Shojaei, Mohammad Bagherniya, Matteo Pirro, Amirhossein Sahebkar

Summary: This systematic review aimed to evaluate the efficacy of phytochemicals on lipid parameters in patients with hypertriglyceridemia (HTG). Forty-eight RCTs including 53 arms and comprising 3,478 HTG patients met the eligibility criteria. Phytochemicals significantly reduced the serum levels of triglycerides, total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B, while increasing high-density lipoprotein cholesterol levels in HTG patients.

PHYTOTHERAPY RESEARCH (2023)

Review Cardiac & Cardiovascular Systems

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

Maciej Banach, Peter E. Penson, Michel Farnier, Zlatko Fras, Gustavs Latkovskis, Ulrich Laufs, Francesco Paneni, Paolo Parini, Matteo Pirro, Zeljko Reiner, Michal Vrablik, Carlos Escobar

Summary: Cardiovascular disease (CVD) is a chronic non-communicable disease and the leading cause of disability and mortality worldwide. The current lipid-lowering treatments need improvement, and bempedoic acid, as a new approach to reduce lipid levels, has the potential to lower the risk of CVD.

PROGRESS IN CARDIOVASCULAR DISEASES (2023)

Article Cardiac & Cardiovascular Systems

Cross-Sectional Gene-Smoking Interaction Analysis in Relation to Subclinical Atherosclerosis-Results From the IMPROVE Study

Buamina Maitusong, Federica J. Laguzzi, Rona Strawbridge, Damiano Baldassarre, Fabrizio E. Veglia, Steve Humphries, Kai Savonen, Sudhir Kurl, Matteo J. Pirro, Andries Smit, Philippe Giral, Angela Silveira, Elena Tremoli, Anders Hamsten, Ulf de Faire, Bruna Gigante, Karin Leander, IMPROVE Study Grp

Summary: The study found that certain genetic variants may modify the effect of smoking on carotid intima-media thickness, increasing the risk of atherosclerosis.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Lipid profile screening and ASCVD prevention

Filippo Figorilli, Massimo Raffaele Mannarino, Amirhossein Sahebkar, Matteo Pirro

Summary: Introduction: Atherosclerotic cardiovascular disease (ASCVD) is the main cause of morbidity and mortality worldwide. Dyslipidemia, especially elevation of LDL-cholesterol levels (LDL-C), is a major cardiovascular risk factor, but often goes undiagnosed due to its asymptomatic course. Strategies aimed at early identification of individuals with elevated LDL-C levels may allow for early intervention to prevent ASCVD development.

EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2023)

No Data Available